BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2021 8:08:20 AM | Browse: 591 | Download: 1617
 |
Received |
|
2021-04-29 06:14 |
|
Peer-Review Started |
|
2021-04-29 06:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-03 03:41 |
|
Revised |
|
2021-07-09 13:52 |
|
Second Decision |
|
2021-07-29 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-29 08:42 |
|
Articles in Press |
|
2021-07-29 08:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-15 14:31 |
|
Publish the Manuscript Online |
|
2021-08-18 08:08 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo and Dong Kyun Park |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea (NRF) funded by the Ministry of Education |
NRF-2020R1F1A1076839 |
|
| Corresponding Author |
Jun-Won Chung, MD, PhD, Professor, Division of Internal Medicine, Department of Gastroenterology, Gachon University College of Medicine, Gil medical Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@hanmail.net |
| Key Words |
Helicobacter pylori; Eradication; Tailored therapy; Concomitant therapy regimen |
| Core Tip |
We investigated the efficacy and safety profiles of a tailored therapy (TT) as a first line Helicobacter pylori (H. pylori) eradication treatment compared to a concomitant therapy (CT) regimen in Korea, where clarithromycin resistance rates are high. Of 217 treatment-naïve H. pylori infection patients, 107 patients were treated with CT and 101 patients with TT. Although the eradication success rate was not statistically different between the groups, the treatment-related side effect rate was significantly lower in the TT group. Therefore, the TT regimen might be a promising solution to overcoming the problem of increased antibiotic resistance rates for Helicobacter eradication. |
| Publish Date |
2021-08-18 08:08 |
| Citation |
Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Kim JH, Seo JY, Park DK. Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients. World J Gastroenterol 2021; 27(31): 5247-5258 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i31/5247.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i31.5247 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
